{
    "code": 0,
    "data": [
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For Quarter And Nine Months Ended December 31 2025",
            "news_body": "Un-audited Financial Results for quarter and nine months ended December 31 2025",
            "news_id": "698fa576-f2c3-4e4d-9785-ae595cefa15f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4bdbc421-668d-46c2-98ea-e564221bea21.pdf",
            "news_date": "2026-02-06 12:44:08",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Standalone & Consolidated Financial Results For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Un-audited Financial Results for the quarter and half year ended September 30 2025",
            "news_id": "648a7e35-c7cf-46d3-a3f2-b823a395e0b8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c54bdc76-b062-4253-8a6d-80c4f1d41d3d.pdf",
            "news_date": "2025-10-31 13:05:29",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Results For The Quarter Ended June 30 2025",
            "news_body": "Unaudited results for the quarter ended June 30 2025",
            "news_id": "b16a0125-7883-4955-8600-dd5bc05b8232",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2dde98ab-c362-4633-b127-e34d36eade54.pdf",
            "news_date": "2025-07-29 13:35:00",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Results For The Quarter And Financial Year Ended March 31 2025",
            "news_body": "Audited Financial results for the quarter and financial year ended March 31 2025",
            "news_id": "2023a534-c6b0-43cc-bd7e-8639dd5a9a13",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94172736-4639-436f-a19c-8c3a94055f96.pdf",
            "news_date": "2025-05-16 13:28:09",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Investors / Analysts Meeting",
            "news_body": "Audio Recording of Investors Meet",
            "news_id": "5ec68d41-239f-4cf7-9c45-152cb6987ce1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8492a875-a254-45c1-8dbf-97bb22cc4ebc.pdf",
            "news_date": "2025-02-24 23:55:54",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Results For The Quarter Ended December 31 2024",
            "news_body": "Unaudited Results for the quarter ended December 31 2024",
            "news_id": "266ae6c6-1fe7-43f0-87ef-bb4b9d3b3c6b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d6a4e2f-6c02-48a1-9492-dabeb981a51c.pdf",
            "news_date": "2025-01-31 13:05:26",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of Unaudited Financial Results For Quarter And Half Year Ended September 30, 2024",
            "news_body": "Approval of Unaudted Financial Results for the quarter and half year ended September 30, 2024",
            "news_id": "7eb50faf-338c-4dd3-bc8c-9f752a078ebc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=349bf8a8-cce9-4870-8269-d95e5b6ae20c.pdf",
            "news_date": "2024-10-25 12:26:18",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For June 30, 2024",
            "news_body": "Unaudited Financial Results for June 30, 2024",
            "news_id": "5d0508a2-d6dd-4deb-a7ca-8e3eb4da6367",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f4c50068-6906-4d8f-ad3a-e2b56af0ee83.pdf",
            "news_date": "2024-07-19 14:08:10",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For March 31, 2024",
            "news_body": "Audited Financial Results for March 31, 2024",
            "news_id": "1302be86-bc80-4b6e-8b8d-23aeacccdb36",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6c39d01-03ae-487e-937d-12457fd8e683.pdf",
            "news_date": "2024-05-29 14:56:42",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Q3 FY 2024 Alongwith Limited Review Report",
            "news_body": "Unaudited Financial Results Q3 FY 2024 alongwith Limited Review Report",
            "news_id": "35871921-1c5d-4320-8a5e-21b9cd57cea2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64f6bb03-ad37-4374-a35c-aacc51461a7e.pdf",
            "news_date": "2024-02-02 14:24:32",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone & Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2023 Alongwith Limited Review Report For The Said Period.",
            "news_body": "Unaudited standalone & Consolidated financial Results for Q2 FY 2024",
            "news_id": "791c1c0a-b354-4623-a784-6b8e46fb832b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54aee475-ea9d-48bc-b42c-216742b4fdaf.pdf",
            "news_date": "2023-10-27 14:28:41",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2023",
            "news_body": "Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2023",
            "news_id": "1d8571ca-8e8f-4447-b963-a4db48514b0a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06ffcf78-8cd7-4eaa-ac72-4aba85b670df.pdf",
            "news_date": "2023-07-19 14:03:33",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Results For The Quarter And Year Ended March 2023",
            "news_body": "Audited Results for the quarter and year ended March 2023",
            "news_id": "5ea2069c-d8d4-4c38-bee2-082c4ebcc2d3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b93f1e1-3d39-4d86-aa8d-0c5bd53e1569.pdf",
            "news_date": "2023-05-29 15:45:58",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of earnings conference call for the quarter and nine months ended December 31, 2022",
            "news_id": "fcd531b2-96ec-4f18-b58a-f1ff1558bea2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=016b00cc-23e6-4946-ba9c-6e3ddbd9307c.pdf",
            "news_date": "2023-02-09 12:20:11",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Link of Audio recording of investors conference call",
            "news_id": "3228bd3e-8ba6-4732-934f-96054f3aa842",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=294a6d26-e84f-4078-b805-3e676432b857.pdf",
            "news_date": "2023-02-03 21:29:54",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Jubilant Pharmova - Q3 FY 2023 Results",
            "news_body": "In terms of Regulation 33 read with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that Board of Directors of Jubilant Pharmova Ltd at its meeting held today i.e. Friday, February 03, 2023 considered and approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended December 31, 2022. <BR> <BR> Copy of the unaudited financials results for the quarter ended December 31, 2022 alongwith Limited Review Reports issued by the Statutory Auditors on the Unaudited Financial Results (Standalone and Consolidated) for the said period and Press Release/Presentation on aforesaid financials is enclosed herewith.<BR> <BR> The Board Meeting commenced at 11:15 a.m. and concluded at 12.50 p.m. All the above mentioned documents will be simultaneously posted on the Company''s website at www.jubilantpharmova.com. You are requested to take note of the same.<BR>",
            "news_id": "268d69f2-c452-4100-a968-b0edca5d12dd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10e83a8d-2c34-43f1-9f24-f73f96d86671.pdf",
            "news_date": "2023-02-03 13:03:36",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Q2FY23 RPT Transactions",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of the Related Party Transactions in the prescribed format for half year ended September 30, 2022.",
            "news_id": "7fc105ef-6b90-4fc0-9364-a5efb54bbe9e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d09bedc-ab5a-456d-a1d8-b2a3c76458ee.pdf",
            "news_date": "2022-11-04 18:41:31",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Link of audio recording",
            "news_id": "b1fcb91f-b219-404d-9d90-3194c814648e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f7210d1-9888-4194-9b37-9da6c2cb0e85.pdf",
            "news_date": "2022-10-22 14:57:22",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Jubilant Pharmova Financial Results Q2 FY 2023",
            "news_body": "In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2022 have been approved by the Board of Directors of the Company at its meeting held today at 11:45 a.m. and concluded at 1.30 p.m. <BR> <BR> Pursuant to the applicable provisions of the Listing Regulations, we enclose the following:<BR> <BR> 1. The Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2022;<BR> <BR> 2. Limited Review Reports on the Unaudited Financial Results (Standalone and Consolidated) for the said period; and<BR> <BR> 3. Copies of the Press Release and Presentation.<BR> <BR> We request you to take the same on record.<BR>",
            "news_id": "9808f845-c3fa-4169-bf99-4f40c6cb5495",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4bfc1fb1-6dc9-44e4-a5f5-df035c01f726.pdf",
            "news_date": "2022-10-21 13:44:56",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the transcript of Analyst and Investor Conference Call for Unaudited financial results for the quarter ended June 30, 2022 conducted after the meeting of Board of Directors held on Tuesday, August 2, 2022.This is for your information and records.",
            "news_id": "49ab77f8-b7df-4ece-9857-9c6139f736bd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0757cee2-24f0-46c9-8e00-5c5e7bdbfbe3.pdf",
            "news_date": "2022-08-08 19:48:23",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "we wish to inform that audio recording of Analyst and Investor Conference Call for Unaudited financial results for the quarter ended June 30, 2022 held on Tuesday, August 2, 2022, has been uploaded on the Company''s website and same is given in the attached letter.",
            "news_id": "95f9b3a6-1fee-48a8-a00a-048bfc7056ab",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51eae07f-e035-48d9-8fa3-668183ef20fc.pdf",
            "news_date": "2022-08-02 22:02:03",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Jubilant Pharmova - Results Q1 FY 23",
            "news_body": "In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2022 were approved by the Board of Directors of the Company at its meeting held today at 11:15 a.m. and concluded at 12.45 p.m.<BR> <BR> Pursuant to the applicable provisions of the Listing Regulations, we enclose the following:<BR> <BR> 1. The Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2022;<BR> 2. Limited Review Reports on the Unaudited Financial Results (Standalone and Consolidated) for the said quarter; and<BR> 3. Copies of the Press Release and Presentation.<BR>",
            "news_id": "079d48b3-1ee4-4226-8e46-7064430e49b7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=682adfff-03fd-4061-94b1-17a110ece948.pdf",
            "news_date": "2022-08-02 12:58:32",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Details Of Related Party Transactions For HYE March'' 2022",
            "news_body": "Details of Related Party Transactions for HYE March'' 2022",
            "news_id": "f09baa17-3e20-4f87-8b36-b0b413f00701",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b8bfbf02-cad6-4204-8652-7e5cd02a7a61.pdf",
            "news_date": "2022-06-10 18:37:45",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the earnings conference call for the quarter and year ended March 31, 2022",
            "news_id": "971c949a-bd8c-4e86-81a7-b45ce876f217",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=478e6514-da3f-4034-8021-636441ae5227.pdf",
            "news_date": "2022-06-02 16:27:05",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that audio recording of Analyst and Investor Conference Call for Audited financial results for the quarter and financial year ended March 31, 2022 held on Friday, May 27, 2022, has been uploaded on the Company''s website. The link to access the audio call recording is:https://www.jubilantpharmova.com/investors/financials/quarterly-resultsThis is for your information and records.",
            "news_id": "26ce111e-9ca6-44ca-a99a-be851def7ddd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ad98d7d-e15c-4e03-a9be-9ef39475a442.pdf",
            "news_date": "2022-05-28 11:17:50",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Jubilant Pharmova - FY22 Results",
            "news_body": "In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2022 were approved by the Board of Directors of the Company at its meeting held today at 1:15 p.m. and concluded at 4.15 p.m. <BR> <BR> Pursuant to the applicable provisions of the Listing Regulations, we enclose the following:<BR> <BR> 1. The Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2022;<BR> <BR> 2. Audit Reports for Standalone and Consolidated Financial Results; <BR> <BR> 3. Copies of the Press Release and Presentation.<BR> <BR> We declare that the Reports of Auditors are with unmodified opinion with respect to the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2022.",
            "news_id": "837d261c-ab84-4c95-a535-24184f477d6e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e966be1d-991d-4636-ba71-865f15b155eb.pdf",
            "news_date": "2022-05-27 16:30:33",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Jubilant Pharmova - Q3 FY 2022 Results",
            "news_body": "In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended December 31, 2021 were approved by the Board of Directors of the Company at its meeting held today at 12.15 p.m. and concluded at 3.20 p.m. <BR>  <BR> Pursuant to the applicable provisions of the Listing Regulations, we enclose the following:<BR> <BR> 1. The Unaudited Financial Results (Standalone and Consolidated) for the quarter ended December 31, 2021;<BR> 2. Limited Review Reports on the Unaudited Financial Results (Standalone and Consolidated) for the said quarter; and<BR> 3. Copies of the Press Release and Presentation.<BR> <BR> We request you to take the same on records.<BR>",
            "news_id": "6d6a0c84-418a-4ef4-90b8-b6826c990645",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3e85c44-4491-4697-857b-6b7de70434c6.pdf",
            "news_date": "2022-02-04 15:32:46",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Jubilant Pharmova Q2 FY 2022",
            "news_body": "Dear Sirs, <BR> In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2021 have been approved by the Board of Directors of the Company at its meeting held today at 1:15 p.m. and concluded at 2.45 p.m. <BR> <BR> Pursuant to the applicable provisions of the Listing Regulations, we enclose the following:<BR> <BR> 1. The Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2021;<BR> <BR> 2. Limited Review Reports on the Unaudited Financial Results (Standalone and Consolidated) for the said period; and<BR> <BR> 3. Copies of the Press Release and Presentation.",
            "news_id": "2ae23787-940a-4a75-9cda-ec627a649944",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec9d4e84-98e9-467c-9fcf-4628dfaec819.pdf",
            "news_date": "2021-10-22 14:57:16",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For Quarter Ended June 30, 2021",
            "news_body": "In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2021 were approved by the Board of Directors of the Company at its meeting held today at 1:30 p.m. and concluded at 4.00 p.m.<BR>  <BR> Pursuant to the applicable provisions of the Listing Regulations, we enclose the following:<BR> <BR> 1. The Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2021;<BR> <BR> 2. Limited Review Reports on the Unaudited Financial Results (Standalone and Consolidated) for the said quarter; and<BR> <BR> 3. Copies of the Press Release and Presentation.<BR> <BR> We request you to take the same on records.<BR>",
            "news_id": "91626ad9-85a0-4f2d-890d-6030e142fd45",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33fbd423-fb7c-4eb5-ac64-0646b302b82d.pdf",
            "news_date": "2021-07-23 16:08:46",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of<BR> Related Party Transactions on a consolidated basis, in the format specified in the accounting standards for the Financial Year ended March 31, 2021.",
            "news_id": "6c45f2be-8d18-499f-96d1-a21f61a93a9a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22f76afe-c31d-4282-8a53-5e0158796fb3.pdf",
            "news_date": "2021-06-29 11:13:51",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In continuation of our letter dated June 10, 2021, we enclose presentation to be made at Investor and Analyst Meet on June 18, 2021.",
            "news_id": "6e34fb4b-a795-4a5f-88ae-5bd206603ba6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=885976f9-369e-4db2-a565-7df37d10f00b.pdf",
            "news_date": "2021-06-18 13:33:30",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "JUBLPHARMA",
            "disp": "Jubilant Pharmova",
            "bse_code": 530019,
            "isin": "INE700A01033",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Quarter And Year Ended March 31, 2021",
            "news_body": "In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2021 were approved by the Board of Directors of the Company at its meeting held today at 1:35 p.m. and concluded at 4.20 p.m. <BR> <BR> Pursuant to the applicable provisions of the Listing Regulations, we enclose the following:<BR> <BR> 1. The Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2021;<BR> <BR> 2. Audit Reports for Standalone and Consolidated Financial Results; <BR> <BR> 3. Copies of the Press Release and Presentation.<BR> <BR> We declare that the Reports of Auditors are with unmodified opinion with respect to the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2021.<BR> <BR>",
            "news_id": "4fcb3b30-8096-40e5-bf87-a3ffd20e03fe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71f935e5-a644-4bf3-91da-ea249a6f1ebd.pdf",
            "news_date": "2021-06-04 16:31:56",
            "seo": "jubilant-life-sciences-ltd",
            "ltp": 937.9,
            "ch": 1.5,
            "pch": 0.1601879538658693,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3637,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}